Literature DB >> 12810534

Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.

Jennifer A Kricker1, Chris L Towne, Sue M Firth, Adrian C Herington, Zee Upton.   

Abstract

Previous studies demonstrated that IGF-II binds directly to vitronectin (VN), whereas IGF-I binds poorly. However, binding of VN to integrins has been demonstrated to be essential for a range of IGF-I-stimulated biological effects, including IGF binding protein (IGFBP)-5 production, IGF type-1 receptor autophosphorylation, and cell migration. Thus, we hypothesized that a link between IGF-I and VN must occur and may be mediated through IGFBPs. This was tested using competitive binding assays with VN and (125)iodine-labeled IGFs in the absence and presence of IGFBPs. IGFBP-4, IGFBP-5, and nonglycosylated IGFBP-3 were shown to significantly enhance binding of IGF-I to VN, whereas IGFBP-2 and glycosylated IGFBP-3 had a smaller effect. Furthermore, binding studies with analogs indicate that glycosylation status and the heparin-binding domain of IGFBP-3 are important in this interaction. To examine the functional significance of IGFs binding to VN, cell migration in MCF7 cells was measured and found to be enhanced when VN was prebound to IGF-I in the presence of IGFBP-5. The effect required IGF:IGFBP:VN complex formation; this was demonstrated by use of a non-IGFBP-binding IGF-I analog. Together, these data indicate the importance of IGFBPs in modulating IGF-I binding to VN and that this binding has functional consequences in cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810534     DOI: 10.1210/en.2002-221086

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  Four loci differentially expressed in muscle tissue depending on water-holding capacity are associated with meat quality in commercial pig herds.

Authors:  Tiranun Srikanchai; Eduard Murani; Klaus Wimmers; Siriluck Ponsuksili
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

Review 2.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

3.  Fibulin-3 promotes muscle-invasive bladder cancer.

Authors:  A L Han; B A Veeneman; L El-Sawy; K C Day; M L Day; S A Tomlins; E T Keller
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

4.  Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.

Authors:  Mikaël M Martino; Priscilla S Briquez; Adrian Ranga; Matthias P Lutolf; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 5.  In vitro selection technologies to enhance biomaterial functionality.

Authors:  Jonah C Rosch; Emma K Hollmann; Ethan S Lippmann
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

6.  Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers.

Authors:  Tony J Parker; James A Broadbent; Jacqui A McGovern; Daniel A Broszczak; Christina N Parker; Zee Upton
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

7.  Controlled release of IGF-1 and HGF from a biodegradable polyurethane scaffold.

Authors:  Devin M Nelson; Priya R Baraniak; Zuwei Ma; Jianjun Guan; N Scott Mason; William R Wagner
Journal:  Pharm Res       Date:  2011-02-23       Impact factor: 4.200

8.  Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.

Authors:  Zee Upton; Hilary J Wallace; Gary K Shooter; Derek R van Lonkhuyzen; Sim Yeoh-Ellerton; Erin A Rayment; Jacqui M Fleming; Daniel Broszczak; Douglas Queen; R Gary Sibbald; David I Leavesley; Michael C Stacey
Journal:  Int Wound J       Date:  2011-10       Impact factor: 3.315

9.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

Review 10.  A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Authors:  Torsten Stein; Nathan Salomonis; Dimitry S A Nuyten; Marc J van de Vijver; Barry A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-30       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.